Key result
Pharmacy-supported transition-of-care interventions significantly reduced the odds of 30-day all-cause readmissions compared with usual care (OR 0.68; 95% CI 0.61-0.75).
Why the study?
Do pharmacy-supported transition-of-care interventions reduce 30-day all-cause readmissions in adult patients discharged to home?
Population
61,858 adult patients discharged to home within the United States across 56 studies
Comparison
Pharmacy-supported transition-of-care… vs Usual care
Design
Meta-analysis
Follow-up
30-day
Authors
Loading...
Supports implementing pharmacy-supported transition-of-care programs to reduce readmissions; confirms benefit across pooled studies.
Meta-Analysis (n=61,858)
Do pharmacy-supported transition-of-care interventions reduce 30-day all-cause readmissions in adult patients discharged to home?
Effect estimate: OR 0.68 (95% CI 0.61-0.75)
Pharmacy-supported transition-of-care programs are associated with a significant 32% reduction in the odds of 30-day all-cause readmissions for adults discharged to home.
Rodrigues et al. (2017) conducted a meta-analysis in Hospital discharge (n=61,858). Pharmacy-supported transition-of-care interventions vs. Usual care was evaluated on 30-day all-cause readmissions (OR 0.68, 95% CI 0.61-0.75). Pharmacy-supported transition-of-care interventions significantly reduced the odds of 30-day all-cause readmissions compared with usual care (OR 0.68; 95% CI 0.61-0.75).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: